Proposal for the functional assessment of acute inflammatory neuropathy (FAAIN) in Guillain-Barré syndrome

References

• Hughes RAC, Wijdicks EFM, Barohn R, et al. Practice parameter: immunotherapy for Guillain-Barré syndrome. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2003;61:736–740.
   PubMed Web of Science ®Google Scholar
• Hughes R, Raphaël J, Swan A, et al. 2000. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev (Complete Rev). Issue. Art. No.: CD002063. DOI:https://doi.org/10.1002/14651858.cd002063.
   Google Scholar
• Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14(11):1103–1109.
   PubMed Web of Science ®Google Scholar
• Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2(5):200–215.
   PubMedGoogle Scholar
• Merkies ISJ, Schmitz PIM, van der Meché FGA, et al. Inflammatory Neuropathy Cause and Treatment (INCAT) group. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatr. 2002;72(5):596–601.
   PubMed Web of Science ®Google Scholar
• Merkies ISJ, Schmitz PIM, van der Meché FGA, et al. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Neurology. 2000;54:943–947.
   PubMed Web of Science ®Google Scholar
• Graham RC, Hughes RAC. A modified peripheral neuropathy scale: the overall neuropathy limitations scale. J Neurol Neurosurg Psychiatry. 2006;77:973–976.
   PubMed Web of Science ®Google Scholar
• Mendell JR, Florence J. Manual muscle testing. Muscle Nerve. 1990;13(supplement):S16–S20.
   PubMedGoogle Scholar
• Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester diabetic neuropathy study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology. 1991;41:799–807.
   PubMed Web of Science ®Google Scholar
• Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195–201.
   PubMed Web of Science ®Google Scholar
• Hugh JW, Bart CJ, van Doorn PA. Guillain-Barré síndrome. Lancet. 2016;388:717–727.
   PubMedGoogle Scholar
• Abdel-Mannan O MBBCh, D’Argenzio L, Pitt M MB BChir, et al. Two cases of Guillain-Barre syndrome. Variants presenting with dysautonomia. Child Neurol Open. 2019;6:1–5.
   Google Scholar
• Ito M, Matsuno K, Sakumoto Y, et al. Ataxic Guillain Barre syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J Neurol Neurosurg Psychiatry. 2011;82:294–299.
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Yuki N. Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome. J Neurol. 2015;262(9):2001–2012.
   PubMed Web of Science ®Google Scholar
• Atsumi M, Kitaguchi M, Nishikawa S, et al. [A variant of Guillain-Barré syndrome with prominent bilateral peripheral facial nerve palsy-facial diplegia and paresthesias]. Rinsho Shinkeigaku. 2004;44(8):549–552.
   PubMedGoogle Scholar
• O’Leary CP, Veitch J, Durward WF, et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry. 1996;61(6):649–651.
   PubMed Web of Science ®Google Scholar
• Odaka M, Yuki N, Yamada M, et al. Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain. 2003;126:2279–2290.
   PubMed Web of Science ®Google Scholar
• Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher- Bickerstaff syndrome). J Neuroimmunol. 2009;215(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Kuwahara M, Morikawa M, et al. Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody. Neurol Neuroimmunol Neuroinflamm. 2020;7(6):1–7.
   Web of Science ®Google Scholar
• Ropper A. Unusual clinical variants and signs in Guillain-Barré Syndrome. Arch Neurol. 1986;43:1150–1152.
   PubMed Web of Science ®Google Scholar
• Kim J, Yuki N. Hemiparetic Guillain–Barré syndrome. J Neurol Sci. 2016;361:131–132.
   PubMed Web of Science ®Google Scholar
• González HA, Fabre PÓ, Díaz NS, et al. Facial diparesis as a presentation of Guillain Barre Syndrome. Med Clin (Barc). 2010;135(13):627–628.
   PubMed Web of Science ®Google Scholar
• van Den Berg B, Fokke C, Drenthen J, et al. Paraparetic Guillain-Barré syndrome. Neurology. 2014;82:1984–1989.
   PubMed Web of Science ®Google Scholar
• Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain. 1986;109:1115–1126.
   PubMed Web of Science ®Google Scholar
• Yuki N, Yoshino H, Sato S, et al. “Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 1990;40(12):1900–1902.
   PubMed Web of Science ®Google Scholar
• McKhann GM, Cornblath DR, Ho T, et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet. 1991;338(8767):593–597.
   PubMed Web of Science ®Google Scholar
• Susuki K. Node of Ranvier disruption in Guillain–Barré síndrome. Clin Exp Neuroimmunol. 2016;7(4):324–329.
   Google Scholar
• Kuitwaard K, van Koningsveld R, Ruts L, et al. Recurrent Guillain–Barre´ síndrome. J Neurol Neurosurg Psychiatry. 2009;80:56–59.
   PubMed Web of Science ®Google Scholar
• Korn-Lubetzki I, Steiner I, Geleijns K. The occurrence of Guillain Barré Syndrome within families. Neurology. 2005;64(9):1665–1666.
   PubMed Web of Science ®Google Scholar
• Mathis S, Soulages A, Le Masson G, et al. History of acute polyradiculoneuropathy (part 2) From 1916 to 2019. Neurology. 2020;94(1):1–5.
   Google Scholar
• Verboon C, Doets AY, Galassi G, et al. Current treatment practice of Guillain-Barré syndrome. Neurology. 2019;93(1):e1–e18.
   PubMed Web of Science ®Google Scholar
• Lestayo O’Farrill Z, Sistach-Vega V, and Rodriguez Álvarez B, et al. Clinical-epidemiological characterization of Guillain Barré syndrome in a Cuban case series. RRNMF Neuromuscular J. 2021;2(2):24–33. https://doi.org/https://doi.org/10.17161/rrnmf.v2i2.15415
   Google Scholar
• Estrada González JR. Perfil clinico de la polirradiculoneuritis aguda tipo Landry-Guillain-Barre-Strohl: algunas conclusiones derivadas del estudio de 140 casos con 18 estudios anatomopatologicos. Rev Cub Med. 1980;19(4):453–464.
   Google Scholar
• Streiner DL. A checklist for evaluating the usefulness of rating scales. Can J Psychiatry. 1993;38:140–148.
   PubMed Web of Science ®Google Scholar
• Hamed Taherdoost H, Sahibuddin S, Jalaliyoon N. Exploratory factor analysis; concepts and theory. Jerzy Balicki. Adv Appl Pure Math. 2014;27, WSEAS:375–382. Mathematics and Computers in Science and Engineering Series, 978-960-474-380-3. ffhal-02557344.
   Google Scholar
• Floyd FJ, Widaman KF. Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess. 1995;7:286–299.
   Web of Science ®Google Scholar
• Fabrigar LR, Wegener DT, MacCallum RC, et al. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods. 1999;4:272–299.
   Web of Science ®Google Scholar
• Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. London: Her Majesty’s Stationary Office; 1976.
   Google Scholar
• Narayanaswami P. The spectrum of functional rating scales in neurology clinical trials. Neurotherapeutics. 2017;14:161–175.
   PubMed Web of Science ®Google Scholar
• de Vet HCW, Terwee CB, Bouter LM. Current challenges in clinimetrics. J Clin Epidemiol. 2003;56:1137–1141.
   PubMed Web of Science ®Google Scholar
• Myers ND, Ahn S, Jin Y. Sample size and power estimates for a confirmatory factor analytic model in exercise and sport: a Monte Carlo approach. Res Q Exerc Sport. 2011;82(3):412–423.
   PubMed Web of Science ®Google Scholar